| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/28/2011 | US20110182882 Icotinib Hydrochloride, Synthesis, Crystalline Forms, Pharmaceutical Compositions, and Uses Thereof |
| 07/28/2011 | US20110182881 Signature and determinants associated with metastasis and methods of use thereof |
| 07/28/2011 | US20110182880 Combination Therapies Against Cancer |
| 07/28/2011 | US20110182879 Novel human transferase family members and uses thereof |
| 07/28/2011 | US20110182877 Sustained delivery of compstatin analogs from gels |
| 07/28/2011 | US20110182876 Methods of Treatment with Elastase |
| 07/28/2011 | US20110182875 Novel class of therapeutic protein based molecules |
| 07/28/2011 | US20110182874 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/28/2011 | US20110182873 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/28/2011 | US20110182872 Methods of analysis of polymorphisms and uses thereof |
| 07/28/2011 | US20110182864 Compositions containing inclusion complexes |
| 07/28/2011 | US20110182858 Silibinin component for the treatment of hepatitis |
| 07/28/2011 | US20110182857 Delivery of Drugs to Mucosal Surfaces |
| 07/28/2011 | US20110182856 Inhibitors of serine proteases |
| 07/28/2011 | US20110182855 Conjugated biological molecules and their preparation |
| 07/28/2011 | US20110182854 Hcv protease inhibitors |
| 07/28/2011 | US20110182853 Platelet derived growth factor (pdgf)-derived neurospheres define a novel class of progenitor cells |
| 07/28/2011 | US20110182852 Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| 07/28/2011 | US20110182851 Oxidized ldl specific antibody-fusion and conjugated proteins |
| 07/28/2011 | US20110182850 Organic compounds and their uses |
| 07/28/2011 | US20110182849 Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents |
| 07/28/2011 | US20110182848 Granulocyte colony stimulating factor |
| 07/28/2011 | US20110182847 Use of tlr agonists and/or type 1 interferons to alleviate toxicity of tnf-r agonist therapeutic regimens |
| 07/28/2011 | US20110182822 Biomarkers for Painful Intervertebral Discs and Methods of Use Thereof |
| 07/28/2011 | US20110182819 Methods and Compounds for Promoting Vessel Regression |
| 07/28/2011 | US20110182818 Methods and compositions for the treatment of symptoms of neurological and mental health disorders |
| 07/28/2011 | US20110182814 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma |
| 07/28/2011 | US20110182813 Amphiphilic copolymers and compositions containing such polymers |
| 07/28/2011 | US20110182811 Nucleotide sequence encoding a modulator of nf-kb |
| 07/28/2011 | US20110182805 Nanoparticle fabrication methods, systems, and materials |
| 07/28/2011 | DE19929802B4 Collagenprodukt und dessen Verwendung Collagen product and its use |
| 07/28/2011 | CA2787812A1 Pan-antiviral peptides for protein kinase inhibition |
| 07/28/2011 | CA2787652A1 Liquid formulations for long-acting erythropoietin conjugate |
| 07/28/2011 | CA2787369A1 Modified melk peptides and vaccines containing the same |
| 07/28/2011 | CA2787331A1 Aromatic-cationic peptides and uses of same |
| 07/28/2011 | CA2787131A1 Pharmaceutical composition for treating a metabolic syndrome |
| 07/28/2011 | CA2786934A1 Treatment of cardiac conditions |
| 07/28/2011 | CA2786690A1 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use |
| 07/28/2011 | CA2781733A1 Delivery system for diagnostic and therapeutic agents |
| 07/27/2011 | EP2348135A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
| 07/27/2011 | EP2348134A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348133A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348114A1 Bone delivery conjugates and method of using same to target proteins to bone |
| 07/27/2011 | EP2348106A1 Chimeric proteins, cells comprising same, and assays using same |
| 07/27/2011 | EP2348050A1 Anti-glycated CD59 antibodies and uses thereof |
| 07/27/2011 | EP2348047A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 07/27/2011 | EP2348045A1 Receptor, use of same and murine antibody |
| 07/27/2011 | EP2348043A1 APO-2 ligand variants and uses thereof |
| 07/27/2011 | EP2348039A2 Cyclic antimicrobial peptides |
| 07/27/2011 | EP2348036A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2348035A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2348034A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2347771A1 Peptide-based compounds for targeted imaging |
| 07/27/2011 | EP2347768A1 Novel use application of sugar chain-recognizing receptor |
| 07/27/2011 | EP2347763A1 An implantable neuroendoprosthesis system, a method for preparing same and a procedure for performing of a reconstructive neurosurgical operation |
| 07/27/2011 | EP2347762A1 Exendin for treating diabetes and reducing body weight |
| 07/27/2011 | EP2347761A1 A composition with inhibition activity on pathological angiogenesis |
| 07/27/2011 | EP2347760A2 Use of follistatin for the manufacture of a medicament for the treatment of a non-degenerative nervous system disorder |
| 07/27/2011 | EP2347730A1 Methods and compositions for delivery of growth factor to fibrous connective tissue |
| 07/27/2011 | EP2346993A1 Efficient expression of truncated human rnaset2 in e.coli |
| 07/27/2011 | EP2346906A1 Conjugates of glp-1 agonists and uses thereof |
| 07/27/2011 | EP2346905A1 Methods and compositions for treatment of myotonic dystrophy |
| 07/27/2011 | EP2346527A1 Medicinal products for the treatment of blood coagulation disorders containing thrombin-free factor xia concentrate |
| 07/27/2011 | EP2346526A2 Compositions of and methods of using ligand dimers |
| 07/27/2011 | EP2346525A1 Methods of modulating the negative chemotaxis of immune cells |
| 07/27/2011 | EP2346524A2 New therapy and medicament using integrin ligands for treating cancer |
| 07/27/2011 | EP2346523A2 A multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia |
| 07/27/2011 | EP2346522A1 Methods of modulating protein homeostasis, metabolic syndrome, heavy metal intoxication and nrf2 transcription factors |
| 07/27/2011 | EP2346521A1 Peptides and methods of use |
| 07/27/2011 | EP2346504A1 Combinations comprising bicyclic s1p lyase inhibitors |
| 07/27/2011 | EP2346503A2 Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia |
| 07/27/2011 | EP2346359A1 Improving peptide availabilty |
| 07/27/2011 | EP2346352A1 Nutritional composition with anti-regurgitation properties |
| 07/27/2011 | EP2029120B1 Nanoparticles containing three various ligands for providing immune responses against infectious agents |
| 07/27/2011 | EP1912995B1 Macrocylic inhibitors of hepatitis c virus |
| 07/27/2011 | EP1578439B1 Low dose methods for treating disorders in which tnf-alpha activity is detrimental |
| 07/27/2011 | EP1435993B1 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/27/2011 | EP1432733B1 Method for identifying gene regulatory peptides |
| 07/27/2011 | EP1366062B1 Efficient recovery of correctly refolded proteins |
| 07/27/2011 | EP1125585B1 Treatment of graft-versus-host disease targeting ailim |
| 07/27/2011 | EP1071805B1 Adenoviral vectors for treating disease |
| 07/27/2011 | EP1011743B1 Loading and release of water-insoluble drugs |
| 07/27/2011 | CN1950502B Regulation of cardiac contractility and heart failure propensity |
| 07/27/2011 | CN1747744B Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 07/27/2011 | CN1309666B Polymer composition of glucuronic acid glucosan |
| 07/27/2011 | CN102137926A Promoting ECM production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system |
| 07/27/2011 | CN102137868A Prophylactic or therapeutic agent for influenza virus infection |
| 07/27/2011 | CN102137680A Methods of treating cancer with APOE peptides |
| 07/27/2011 | CN102134609A Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 07/27/2011 | CN102134277A Soluble VEGFR (Vascular Endothelial Growth Factor Receptor) difunctional chimera receptor VEGFR31-Ig as well as preparation method and application thereof |
| 07/27/2011 | CN102134274A tGLP-1 derivative as well as preparation and application thereof |
| 07/27/2011 | CN102133430A Inductive agent for regeneration of periodontium tissue of temperature sensitivity and preparation method thereof |
| 07/27/2011 | CN102133416A Compound protein air-purifying deodorizer (deodorant liquid) |
| 07/27/2011 | CN102133397A Oncotherapy type heparanase MAP vaccine |
| 07/27/2011 | CN102133395A Skeleton health-care product or medicinal composite and application thereof |
| 07/27/2011 | CN102133394A Compound insulin preparation |
| 07/27/2011 | CN102133393A Acidic insulin preparations with improved stability |
| 07/27/2011 | CN102133392A Water splashing compound preparation for boosting exuviation of shrimps and crabs, hardening shells, preventing diseases and resisting stresses |
| 07/27/2011 | CN102133391A Autoserum compound for nourishing skin mesoderm and preparation method thereof |
| 07/27/2011 | CN102133390A Calcium tablets and production process |